MDS Virtual Congress 2021

September 17-22, 2021. Virtual Congress. www.mdscongress.org

View by Title View Categories

Jump to: View All • a b c d e f g h i j k l m n o p q r s t u [v] w x y z

Validation of a real- time monitoring system to detect motor symptoms in patients with Parkinson´s disease treated with Levodopa Carbidopa Intestinal Gel

A. Bougea, M. Palkopoulou, S. Pantinaki, A. Antonoglou, E. Efthymiopoulou (Athens, Greece)
Validation of biomarkers in Huntington’s disease to support the development of disease-modifying therapies: a systematic review and critical appraisal scheme

H. Tang, T. van Eimeren, C. Sampaio, T. Mestre (Ottawa, Canada)
Validation of postural tremor model using regression and optimization

S. Ward, S. Charles, D. Farina, M. Allen (Mapleton, USA)
Validation of smartphone-based active tests with structural neuroimaging in Huntington’s disease

J. Rennig, S. Holiga, D. Hawellek, F. Lipsmeier, J. Dorn, S. Schobel, C. Simillion, M. Lindemann (Basel, Switzerland)
Validation of the Neuroprotective Potential of SLP-2 against alpha-synuclein neuropathology in a Mouse Model of Parkinson’s Disease

C. Bolduc, M. Lorente Picón, S. Laouafa, J. Soliz, I. Pichler, M. Lévesque (Québec, Canada)
Validation of the Thai version of the MDS-UPDRS

P. Jagota, P. Srivanitchapoom, S. Petchrutchatachart, S. Singmaneesakulchai, A. Pisarnpong, P. Lolekha, S. Setthawatcharawanich, P. Chairangsaris, N. Limotai, P. Mekawichai, P. Panyakaew, O. Phokaewvarangkul, J. Sringean, N. Lapelle, P. Martinez-Martin, S. Luo, G. Stebbins, C. Goetz, R. Bhidayasiri (Bangkok, Thailand)
Validation of the UCLA Loneliness Scale in Parkinson’s Disease During a Period of Social Distancing

I. Subramanian, J. Farahnik, L. Mischley (Los Angeles, USA)
Validity and Reliability of Timed Get-Up and Go Test and Unified Parkinson’s disease Rating Scales on Parkinson ’s disease

T. T (Bangalore, India)
Validity of quantitative parameters for analyzing gait motion in PD patients after STN-DBS

J. Ide, K. Goto, T. Sugi (Fukuoka, Japan)
Variability of tremor is not always functional: A feasibility study on the aetiological differentiation of tremor

S. Virameteekul, P. Panyakaew, R. Bhidayasiri (Bangkok, Thailand)
Ventilatory function and respiratory muscle strength in Parkinson’s disease at the early stage: observational study.

R. Gonçalves, N. de Souza, J. Barbosa Neto, C. Araújo, J. Veras, T. de Freitas, P. Cortez, C. Do Amaral, L. Cardoso, D. Dalles, E. Andrade (Manaus, Brazil)
Virtual reality for balance and mobility in Parkinson’s disease: systematic review and meta-analysis

E. Sarasso, A. Gardoni, A. Tettamanti, F. Agosta, M. Filippi, D. Corbetta (Milan, Italy)
Virtual Rehabilitation for Functional Movement Disorder

H. Bhatt, L. Macgillivray, K. Marcelle, S. Lidstone (Toronto, Canada)
Visual cognition differences between asymptomatic and symptomatic carriers of Huntington’s disease (HD)

M. Turuelo, MA. Acera, M. Diez-Cirarda, T. Fernández, B. Tijero, M. Carmona, M. Ruiz, J. Somme, J. Ruiz, A. Gabilondo, I. Croitoru, L. Pardina, N. Ayo, A. Murueta-Goyena, I. Gabilondo, JC. Gómez-Esteban, R. Del Pino (Barakaldo, Spain)
Visual Impairment along Parkinsonism Development and the Association to Non-vision dependent Cognitive Decline: A Prospective Nation-wide CLSA study

C. Yao, A. Szpindel, S. Fereshtehnejad, A. Pelletier, C. Wolfson, R. Postuma (Montréal, Canada)
Visualising tau in patients with progressive supranuclear palsy using PI2620-PET

L. Vivash, HM. Tang, K. Bertram, TJ. O'Brien (Melbourne, Australia)
Visualization Tool for DBS Programming with a Multiple Source, Constant Current System Reduces Initial Programming Time

J. Aldred, T. Zesiewicz, Y. Bezchlibnyk, J. Carlson, L. Chen, R. Jain (Spokane, USA)
Visuo-cognitive training in Parkinson’s disease: Protocol for a randomised cross-over trial.

J. Das, R. Morris, G. Barry, R. Walker, S. Stuart (Newcastle Upon Tyne, United Kingdom)
Vitamin D and Parkinson’s disease

D. Novotnyy (Novosibirsk, Russian Federation)
VMAT2 availability in Parkinson’s Disease with Rapid Eye Movement Sleep Behaviour Disorder

M. Valli, SS. Cho, C. Uribe, M. Masellis, R. Chen, A. Mihaescu, A. Strafella (Toronto, Canada)
VMAT2 OVEREXPRESSION REDUCES INTRACELLULAR NEUROMELANIN LEVELS AND ATTENUATES PARKINSON-LIKE PATHOLOGY IN NEUROMELANIN-PRODUCING PARKINSONIAN RATS

J. Compte, M. González, A. Nicolau, T. Cuadros, J. Romero, A. Parent, A. Laguna, M. Vila (Barcelona, Spain)
VPS35 D620N knockin mice recapitulate cardinal features of Parkinson’s disease

MY. Niu, J. Liu (Shanghai, China)

Jump to: View All • a b c d e f g h i j k l m n o p q r s t u [v] w x y z